Skip to main content
. Author manuscript; available in PMC: 2021 Apr 6.
Published in final edited form as: J Neurointerv Surg. 2019 Sep 4;12(4):374–379. doi: 10.1136/neurintsurg-2019-015225

Table 3.

Outcomes of patients based on the FDA indication for stenting

FDA on-label stenting* (n = 113) FDA off-label stenting (n 100) P-value
Combined outcome 30 15.9% (18) 12% (12) 0.437
Ischemic Stroke 30 9.7% (11) 9% (9) 1.000
Death at 30 days 2.7% (3) 1% (1) 0.624
*

Two or more strokes despite medical therapy is not accounted for, n = number of patients